Clinical Trials
12
Trial Phases
1 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (11 trials with phase data)• Click on a phase to view related trials
Phase 1, Open-label, Drug-drug Interaction Study to Assess Effect Between Radiprodil and the Co-administered Drugs.
- Conditions
- Tuberous Sclerosis Complex (TSC)Focal Cortical DysplasiaOther Neurological Disorders
- Interventions
- Drug: Radiprodil + co-administered drugs
- First Posted Date
- 2025-05-16
- Last Posted Date
- 2025-06-05
- Lead Sponsor
- GRIN Therapeutics, Inc.
- Target Recruit Count
- 18
- Registration Number
- NCT06975605
- Locations
- 🇦🇺
Nucleus Network Melbourne, Melbourne, Victoria, Australia
Study to Evaluate the Pharmacokinetics and Safety Effects Following Coadministration of Carbamazepine or Itraconazole With Radiprodil in Healthy Adults
- Conditions
- Tuberous Sclerosis Complex (TSC)Focal Cortical DysplasiaOther Neurological Disorders
- Interventions
- Drug: Radiprodil with CarbamazepineDrug: Radiprodil with Itraconazole
- First Posted Date
- 2025-05-11
- Last Posted Date
- 2025-05-22
- Lead Sponsor
- GRIN Therapeutics, Inc.
- Target Recruit Count
- 36
- Registration Number
- NCT06965881
- Locations
- 🇦🇺
Q-Pharm Pty Ltd, Brisbane, Queensland, Australia
🇦🇺Nucleus Network Pty Ltd, Melbourne, Victoria, Australia
Astroscape: A Study of Radiprodil on Safety, Tolerability, Pharmacokinetics, and Effect on Seizures and Behavioral Symptoms in Patients With TSC or FCD Type II
- Conditions
- Focal Cortical DysplasiaTuberous Sclerosis Complex
- Interventions
- First Posted Date
- 2024-04-30
- Last Posted Date
- 2025-07-03
- Lead Sponsor
- GRIN Therapeutics, Inc.
- Target Recruit Count
- 30
- Registration Number
- NCT06392009
- Locations
- 🇦🇺
Queensland Children Hospital, South Brisbane, Australia
🇧🇪Universitair Ziekenhuis Antwerpen (UZA), Antwerp, Belgium
🇧🇪University Hospitals Leuven, Pediatric Neurology, Leuven, Belgium
Honeycomb: Evaluation of Radiprodil in Children with GRIN-related Disorder
- First Posted Date
- 2023-04-19
- Last Posted Date
- 2024-11-15
- Lead Sponsor
- GRIN Therapeutics, Inc.
- Target Recruit Count
- 24
- Registration Number
- NCT05818943
- Locations
- 🇺🇸
Mid-Atlantic Epilepsy and Sleep Center, Bethesda, Maryland, United States
🇺🇸Columbia University Irving Medical Center, Dept of Neurology, New York, New York, United States
🇦🇺Queensland Children's Hospital, South Brisbane, Queensland, Australia